Edwards Lifesciences Other countries — Carryforward Amount increased by 11.1% to $575.40M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 11.1%, from $517.80M to $575.40M. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests higher potential for future tax shields, while a decrease may indicate utilization of these assets or expiration.
Represents the total gross amount of tax loss or credit carryforwards available for use in international jurisdictions o...
Standard deferred tax asset disclosure found in the tax footnote of most multinational corporations.
ew_segment_other_countries_carryforward_amount| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $353.30M | $390.50M | $416.50M | $517.80M | $575.40M |
| QoQ Change | — | +10.5% | +6.7% | +24.3% | +11.1% |
| YoY Change | — | +10.5% | +6.7% | +24.3% | +11.1% |